Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 8/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1695268 | 0.83 | GAA (0.37) | GAAHTTPKMKMT2AALDH1A1 | |
| SCHEMBL22260995 | 0.82 | GAA (0.36) | GAAHTTPKMKMT2AALDH1A1 | |
| SCHEMBL1695272 | 0.81 | GAA (0.36) | GAAHTTPKMKMT2AALDH1A1 | |
| SCHEMBL7212084 | 0.78 | GAA (0.37) | GAAHTTPKMKMT2AALDH1A1 | |
| SCHEMBL22260997 | 0.77 | GAA (0.34) | GAAHTTPKMKMT2AALDH1A1 | |
| SCHEMBL28473328 | 0.77 | GAA (0.36) | GAAHTTPKMKMT2AALDH1A1 | |
| SCHEMBL21822067 | 0.76 | GAA (0.37) | GAAHTTPKMKMT2AALDH1A1 | |
| SCHEMBL29612236 | 0.76 | GAA (0.34) | GAAHTTPKMKMT2AALDH1A1 | |
| SCHEMBL2319233 | 0.76 | NR5A2 (0.35) | GAAHTTPKMALDH1A1KDM4E | |
| SCHEMBL3836055 | 0.75 | GAA (0.37) | GAAHTTPKMKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9546261-B2 | Stabilizing of organic material with amino-triazine based mannich-compounds | BOREALIS AG (AT) | 2017-01-17 | — | — | US | disclosed |
| US-20140235766-A1 | Stabilizing of Organic Material with Amino-Triazine Based Mannich-Compounds | BOREALIS AG (AT) | 2014-08-21 | — | — | US | disclosed |
| EP-1110999-A2 | Stabilizing mixtures for organic polymers | Great Lakes Chemical (Europe) GmbH (CH) | 2001-06-27 | — | — | EP | disclosed |
| US-5283273-A | With sterically hindered amine; zinc, calcium, magnesium and/or barium compound; a 1,3-dicarbonyl compound: no organotin or hydrotalcite compounds and no blowing or foaming agents | CIBA-GEIGY CORPORATION (US) | 1994-02-01 | — | — | US | disclosed |
| US-5198130-A | Zinc thiophosphates, tetramethylpiperidine derivatives | CIBA-GEIGY CORPORATION (US) | 1993-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140235766-A1 | Stabilizing of Organic Material with Amino-Triazine Based Mannich-Compounds | PCNA, SOD1, UBE2M | GAA 3145/4885HTT 634/4885PKM 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.